William Woods
Stock Analyst at B. Riley Securities
(0.49)
# 4,203
Out of 5,147 analysts
12
Total ratings
23.08%
Success rate
-12.42%
Average return
Main Sectors:
Stocks Rated by William Woods
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Initiates: Buy | $7 | $1.77 | +295.48% | 1 | Jan 9, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $560 → $670 | $432.00 | +55.09% | 1 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiates: Buy | $5 | $1.71 | +192.40% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Reiterates: Buy | $2 → $3 | $1.09 | +175.23% | 1 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $12 → $10 | $2.67 | +274.53% | 3 | Nov 18, 2025 | |
| IMUX Immunic | Reiterates: Buy | $6 → $5 | $1.02 | +390.20% | 3 | May 23, 2025 | |
| VERU Veru Inc. | Initiates: Buy | $50 | $2.58 | +1,837.98% | 1 | May 14, 2024 | |
| KRMD KORU Medical Systems | Reiterates: Buy | $4 | $4.77 | -16.14% | 1 | Mar 14, 2024 |
Palisade Bio
Jan 9, 2026
Initiates: Buy
Price Target: $7
Current: $1.77
Upside: +295.48%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $560 → $670
Current: $432.00
Upside: +55.09%
OKYO Pharma
Dec 8, 2025
Initiates: Buy
Price Target: $5
Current: $1.71
Upside: +192.40%
Cognition Therapeutics
Nov 21, 2025
Reiterates: Buy
Price Target: $2 → $3
Current: $1.09
Upside: +175.23%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.67
Upside: +274.53%
Immunic
May 23, 2025
Reiterates: Buy
Price Target: $6 → $5
Current: $1.02
Upside: +390.20%
Veru Inc.
May 14, 2024
Initiates: Buy
Price Target: $50
Current: $2.58
Upside: +1,837.98%
KORU Medical Systems
Mar 14, 2024
Reiterates: Buy
Price Target: $4
Current: $4.77
Upside: -16.14%